Annual CFI
-$681.80 K
-$681.80 K-100.00%
31 July 2024
Summary:
BriaCell Therapeutics annual cash flow from investing activities is currently -$681.80 thousand, with the most recent change of -$681.80 thousand (-100.00%) on 31 July 2024. BCTX annual CFI is now -162.46% below its all-time high of $1.09 million, reached on 31 July 2019.BCTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$75.00 K
+$381.80 K+83.58%
31 October 2024
Summary:
BriaCell Therapeutics quarterly cash flow from investing activities is currently -$75.00 thousand, with the most recent change of +$381.80 thousand (+83.58%) on 31 October 2024. Over the past year, it has dropped by -$75.00 thousand (-100.00%). BCTX quarterly CFI is now -103.61% below its all-time high of $2.08 million, reached on 31 July 2018.BCTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$756.80 K
-$75.00 K-11.00%
31 October 2024
Summary:
BriaCell Therapeutics TTM cash flow from investing activities is currently -$756.80 thousand, with the most recent change of -$75.00 thousand (-11.00%) on 31 October 2024. Over the past year, it has dropped by -$756.80 thousand (-100.00%). BCTX TTM CFI is now -124.63% below its all-time high of $3.07 million, reached on 30 April 2019.BCTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -100.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | -162.5% | - | - |
BCTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at low | +83.6% | at low | |||
| 5 y | 5 years | -162.5% | at low | +83.6% | at low | ||
| alltime | all time | -162.5% | +80.9% | -103.6% | +97.4% | -124.6% | +83.9% |
BriaCell Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$75.00 K(-83.6%) | -$756.80 K(+11.0%) |
| July 2024 | -$681.80 K(<-9900.0%) | -$456.80 K(+103.0%) | -$681.80 K(+203.0%) |
| Apr 2024 | - | -$225.00 K(<-9900.0%) | -$225.00 K(<-9900.0%) |
| Jan 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2023 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| July 2020 | $0.00(-100.0%) | - | - |
| July 2019 | $1.09 M(-340.7%) | $95.00 K(+1133.8%) | $1.09 M(-64.5%) |
| Apr 2019 | - | $7700.00(-98.6%) | $3.07 M(+1357.1%) |
| Jan 2019 | - | $531.60 K(+16.2%) | $210.90 K(-383.5%) |
| Oct 2018 | - | $457.30 K(-78.0%) | -$74.40 K(-83.6%) |
| July 2018 | -$453.60 K(-476.7%) | $2.08 M(-172.7%) | -$453.60 K(-80.9%) |
| Apr 2018 | - | -$2.85 M(-1259.0%) | -$2.37 M(-416.4%) |
| Jan 2018 | - | $246.30 K(+215.4%) | $750.00 K(-29.0%) |
| Oct 2017 | - | $78.10 K(-50.3%) | $1.06 M(+776.8%) |
| July 2017 | $120.40 K(-24.2%) | $157.00 K(-41.5%) | $120.40 K(-115.8%) |
| Apr 2017 | - | $268.60 K(-51.3%) | -$759.90 K(-19.0%) |
| Jan 2017 | - | $552.00 K(-164.4%) | -$938.60 K(+34.4%) |
| Oct 2016 | - | -$857.20 K(+18.5%) | -$698.30 K(-539.5%) |
| July 2016 | $158.80 K(-150.2%) | -$723.30 K(-904.6%) | $158.90 K(-88.1%) |
| Apr 2016 | - | $89.90 K(-88.7%) | $1.33 M(-1.5%) |
| Jan 2016 | - | $792.30 K(>+9900.0%) | $1.35 M(-527.5%) |
| Oct 2015 | - | $0.00(-100.0%) | -$316.20 K(0.0%) |
| July 2015 | -$316.20 K(-223.0%) | $448.60 K(+304.9%) | -$316.20 K(-53.3%) |
| Apr 2015 | - | $110.80 K(-112.7%) | -$677.10 K(-3.8%) |
| Jan 2015 | - | -$875.60 K(-1098.4%) | -$704.10 K(-373.8%) |
| July 2014 | $257.10 K | $87.70 K(+4.7%) | $257.20 K(-5.2%) |
| Apr 2014 | - | $83.80 K(+1370.2%) | $271.20 K(+27.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2014 | - | $5700.00(-92.9%) | $212.00 K(-194.4%) |
| Oct 2013 | - | $80.00 K(-21.3%) | -$224.60 K(+79.1%) |
| July 2013 | -$125.40 K(-93.4%) | $101.70 K(+313.4%) | -$125.40 K(-84.2%) |
| Apr 2013 | - | $24.60 K(-105.7%) | -$795.40 K(-15.4%) |
| Jan 2013 | - | -$430.90 K(-340.5%) | -$940.30 K(+30.6%) |
| Oct 2012 | - | $179.20 K(-131.5%) | -$719.80 K(-62.2%) |
| July 2012 | -$1.90 M(-46.6%) | -$568.30 K(+372.4%) | -$1.90 M(-54.0%) |
| Apr 2012 | - | -$120.30 K(-42.8%) | -$4.13 M(-12.2%) |
| Jan 2012 | - | -$210.40 K(-79.0%) | -$4.70 M(+4.3%) |
| Oct 2011 | - | -$1.00 M(-64.1%) | -$4.51 M(+26.5%) |
| July 2011 | -$3.56 M(+731.0%) | -$2.80 M(+302.8%) | -$3.56 M(+306.0%) |
| Apr 2011 | - | -$694.30 K(+4591.2%) | -$877.90 K(+87.1%) |
| Jan 2011 | - | -$14.80 K(-74.7%) | -$469.20 K(+7.8%) |
| Oct 2010 | - | -$58.40 K(-47.1%) | -$435.20 K(+1.4%) |
| July 2010 | -$428.90 K(+175.8%) | -$110.40 K(-61.3%) | -$429.00 K(-3.3%) |
| Apr 2010 | - | -$285.60 K(-1587.5%) | -$443.70 K(+135.4%) |
| Jan 2010 | - | $19.20 K(-136.8%) | -$188.50 K(-9.2%) |
| Oct 2009 | - | -$52.20 K(-58.3%) | -$207.70 K(+33.6%) |
| July 2009 | -$155.50 K(+527.0%) | -$125.10 K(+311.5%) | -$155.50 K(+181.7%) |
| Apr 2009 | - | -$30.40 K(<-9900.0%) | -$55.20 K(+122.6%) |
| Jan 2009 | - | $0.00(0.0%) | -$24.80 K(0.0%) |
| Oct 2008 | - | $0.00(-100.0%) | -$24.80 K(0.0%) |
| July 2008 | -$24.80 K(<-9900.0%) | -$24.80 K(<-9900.0%) | -$24.80 K(<-9900.0%) |
| Apr 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| July 2007 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2006 | - | $0.00 | $0.00 |
| July 2006 | $0.00 | - | - |
FAQ
- What is BriaCell Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual CFI year-on-year change?
- What is BriaCell Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly CFI year-on-year change?
- What is BriaCell Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for BriaCell Therapeutics?
- What is BriaCell Therapeutics TTM CFI year-on-year change?
What is BriaCell Therapeutics annual cash flow from investing activities?
The current annual CFI of BCTX is -$681.80 K
What is the all time high annual CFI for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual cash flow from investing activities is $1.09 M
What is BriaCell Therapeutics annual CFI year-on-year change?
Over the past year, BCTX annual cash flow from investing activities has changed by -$681.80 K (-100.00%)
What is BriaCell Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BCTX is -$75.00 K
What is the all time high quarterly CFI for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly cash flow from investing activities is $2.08 M
What is BriaCell Therapeutics quarterly CFI year-on-year change?
Over the past year, BCTX quarterly cash flow from investing activities has changed by -$75.00 K (-100.00%)
What is BriaCell Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BCTX is -$756.80 K
What is the all time high TTM CFI for BriaCell Therapeutics?
BriaCell Therapeutics all-time high TTM cash flow from investing activities is $3.07 M
What is BriaCell Therapeutics TTM CFI year-on-year change?
Over the past year, BCTX TTM cash flow from investing activities has changed by -$756.80 K (-100.00%)